Research explainer

What is Tesamorelin?

Research use only. The summary below reflects reports in research literature. It is not medical advice or instructions for human use. Tesamorelin is sold strictly for research and analytical purposes.

What is Tesamorelin?

Tesamorelin is a stabilised GHRH (growth-hormone-releasing hormone) analogue, supplied for research as a pre-filled multi-dose pen. Unlike the weekly incretins, it is dosed daily.

It is studied for its effect on the growth-hormone axis and on visceral (deep abdominal) fat in metabolic research. Research outcomes vary with dose and duration.

Reported side effects

  • Injection-site redness or itching — the most commonly reported effect.
  • Fluid retention and joint or muscle aches (GH-axis related) at higher doses.
  • Changes in glucose handling reported in the research literature.

How to dose Tesamorelin

Dosed once daily, typically in the evening — a common research range is 1 mg building to 2 mg. The multi-dose pen sets each dose precisely; no mixing.

Read the full Tesamorelin dosing protocol

How to get Tesamorelin

The Body Pharm Tesamorelin pen is a sealed, HPLC-tested device with a published Certificate of Analysis and free, discreet UK delivery. Sold strictly for research use only.

Cost per month

Confirmed on release — reserve free on the waitlist, no payment taken.

Reserve the pen
Body Pharm Tesamorelin 32

Published HPLC COA · free discreet UK delivery

View Tesamorelin pen
ByThe Body Pharm Research Team· Updated 22 September 2026

All Body Pharm products are sold strictly for research and analytical purposes only. Not for human consumption.